IVRO

 
Common Stock Alternative Reporting
Pink Current Information
Verified Company Profile 5/12/2017
Contact Info
  • 330 E. Orangethorpe Ave., Suite D
  • Placentia, CA 92870

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Oct 10, 1997
Audited Financials Audited
Latest Report Jun 30, 2017 Quarterly Report
CIK 0000872610
Fiscal Year End 9/30
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: CA, USA
Year of Inc. 1985
Employees 4 a/o Aug 22, 2017
Company Officers/Contacts
W. Richard Ulmer President, CEO
Cathy Lynn Richmond CFO
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm
PDM, LLP
3460 Torrance Blvd.
Ste 200
Torrance, CA, 90503
United States
 
Securities Counsel
Haddan & Zepfel LLP
500 Newport Center Drive
Suite 580
Newport Beach, CA, 92660
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Ropak Laboratories to 4-92
IVRO Security Details
Share Structure
Market Value1 $779,366 a/o Sep 21, 2017
Authorized Shares 40,000,000 a/o May 10, 2017
Outstanding Shares 21,953,976 a/o May 10, 2017
-Restricted 7,616,180 a/o May 10, 2017
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Pacific Stock Transfer Co.
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 2,414 (0%)
Jul 14, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security